Dentsply International Inc. (NASDAQ:XRAY) CEO James G. Mosch sold 30,400 shares of Dentsply International stock in a transaction on Thursday, November 17th. The shares were sold at an average price of $60.93, for a total value of $1,852,272.00. Following the completion of the transaction, the chief executive officer now owns 75,283 shares in the company, valued at approximately $4,586,993.19. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Dentsply International Inc. (NASDAQ:XRAY) traded down 0.50% on Monday, hitting $59.86. The company had a trading volume of 267,041 shares. The firm’s 50 day moving average price is $59.01 and its 200 day moving average price is $61.05. Dentsply International Inc. has a 12-month low of $53.43 and a 12-month high of $65.83.

Dentsply International (NASDAQ:XRAY) last posted its quarterly earnings results on Friday, November 4th. The company reported $0.66 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.63 by $0.03. Dentsply International had a net margin of 11.15% and a return on equity of 8.04%. The business had revenue of $954.20 million for the quarter, compared to the consensus estimate of $967.68 million. During the same period in the prior year, the business posted $0.66 earnings per share. Dentsply International’s revenue for the quarter was up 47.0% compared to the same quarter last year. On average, equities analysts expect that Dentsply International Inc. will post $2.77 earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for Dentsply International (NASDAQ:XRAY)

A number of research analysts recently weighed in on XRAY shares. Barrington Research cut Dentsply International from an “outperform” rating to a “market perform” rating in a report on Monday, August 8th. Zacks Investment Research cut Dentsply International from a “buy” rating to a “hold” rating in a report on Monday, August 8th. Jefferies Group reiterated a “buy” rating on shares of Dentsply International in a report on Wednesday, August 17th. Bank of America Corp. started coverage on Dentsply International in a report on Monday, September 12th. They issued a “buy” rating and a $70.00 target price on the stock. Finally, JPMorgan Chase & Co. assumed coverage on Dentsply International in a report on Thursday, September 22nd. They issued a “neutral” rating and a $65.00 target price on the stock. One analyst has rated the stock with a sell rating, four have given a hold rating and six have given a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $67.33.

Institutional investors have recently bought and sold shares of the company. Epoch Investment Partners Inc. acquired a new position in Dentsply International during the third quarter valued at approximately $71,369,000. Price T Rowe Associates Inc. MD increased its position in Dentsply International by 6.4% in the third quarter. Price T Rowe Associates Inc. MD now owns 14,126,303 shares of the company’s stock valued at $839,526,000 after buying an additional 850,914 shares during the last quarter. Victory Capital Management Inc. increased its position in Dentsply International by 128.2% in the third quarter. Victory Capital Management Inc. now owns 1,377,567 shares of the company’s stock valued at $81,870,000 after buying an additional 773,914 shares during the last quarter. Bessemer Group Inc. increased its position in Dentsply International by 41.3% in the second quarter. Bessemer Group Inc. now owns 2,513,795 shares of the company’s stock valued at $155,955,000 after buying an additional 735,375 shares during the last quarter. Finally, BlackRock Advisors LLC increased its position in Dentsply International by 169.8% in the second quarter. BlackRock Advisors LLC now owns 716,057 shares of the company’s stock valued at $44,424,000 after buying an additional 450,653 shares during the last quarter. 94.23% of the stock is currently owned by institutional investors and hedge funds.

About Dentsply International

DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.

5 Day Chart for NASDAQ:XRAY

Receive News & Stock Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related stocks with our FREE daily email newsletter.